Phase3 Study of SFPP in Patients with Osteoarthritis of the knee (Randomized, Parallel Group, Active Comparator-Controlled Study)
Phase 3
- Conditions
- Osteoarthritis of the knee
- Registration Number
- JPRN-jRCT2080221651
- Lead Sponsor
- Taisho Pharmaceutical co., LTD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 620
Inclusion Criteria
Outpatient able to walk
- Patients who agreed to X-ray diagnosis criteria: Kellegren-Lawrence grade 2-3.
etc.
Exclusion Criteria
- History of surgery on the knee joint (including arthroscopy).
- Having critical hepatic disease, renal disease, heart disease and hematologic disease and malignant tumor.
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of pain on a Visual Analogue Scale (VAS)
- Secondary Outcome Measures
Name Time Method Changes in clinical symptoms , General Improvement Rating